251
|
Ablikim M, Achasov MN, Alberto D, Ambrose DJ, An FF, An Q, An ZH, Bai JZ, Baldini Ferroli RBF, Ban Y, Becker J, Berger N, Bertani MB, Bian JM, Boger E, Bondarenko O, Boyko I, Briere RA, Bytev V, Cai X, Calcaterra AC, Cao GF, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen Y, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denysenko I, Destefanis M, Ding Ding WL, Ding Y, Dong LY, Dong MY, Du SX, Fang J, Fang SS, Feng CQ, Fu CD, Fu JL, Gao Y, Geng C, Goetzen K, Gong WX, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo YP, Han YL, Hao XQ, Harris FA, He KL, He M, He ZY, Heng YK, Hou ZL, Hu HM, Hu JF, Hu T, Huang B, Huang GM, Huang JS, Huang XT, Huang YP, Hussain T, Ji CS, Ji Q, Ji XB, Ji XL, Jia LK, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kalantar-Nayestanaki N, Kavatsyuk M, Kuehn W, Lai W, Lange JS, Leung JKC, Li CH, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li K, Li L, Li NB, Li QJ, Li SL, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Liu BJ, Liu CL, Liu CX, Liu CY, Liu FH, Liu F, Liu F, Liu H, Liu HB, Liu HH, Liu HM, Liu HW, Liu JP, Liu K, Liu K, Liu KY, Liu Q, Liu SB, Liu X, Liu XH, Liu YB, Liu Y, Liu ZA, Liu Z, Liu Z, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Ma CL, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XY, Maggiora M, Malik QA, Mao H, Mao YJ, Mao ZP, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Muchnoi NY, Nefedov Y, Nikolaev IB, Ning Z, Olsen SL, Ouyang Q, Pacetti SP, Park JW, Pelizaeus M, Peters K, Ping JL, Ping RG, Poling R, Pun CSJ, Qi M, Qian S, Qiao CF, Qin XS, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schulze J, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun XD, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Thorndike EH, Tian HL, Toth D, Varner GS, Wan X, Wang B, Wang BQ, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang Q, Wang QJ, Wang SG, Wang XF, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wen QG, Wen SP, Wiedner U, Wu LH, Wu N, Wu W, Wu Z, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu GM, Xu H, Xu QJ, Xu XP, Xu Y, Xu ZR, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang T, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yu BX, Yu CX, Yu SP, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo AZ, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang J, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang SH, Zhang TR, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang YS, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao J, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zheng ZP, Zhong B, Zhong J, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu XW, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH, Zuo JX. First observation of η(1405) decays into f(0)(980)π0. PHYSICAL REVIEW LETTERS 2012; 108:182001. [PMID: 22681064 DOI: 10.1103/physrevlett.108.182001] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/14/2012] [Indexed: 06/01/2023]
Abstract
The decays J/ψ → γ π+ π- π0 and J/ψ → γ π0 π0 π0 are analyzed using a sample of 225×10(6) J/ψ events collected with the BESIII detector. The decay of η(1405) → f(0)(980)π0 with a large isospin violation is observed for the first time. The width of the f(0)(980) observed in the dipion mass spectra is anomalously narrower than the world average. Decay rates for three-pion decays of the η' are also measured precisely.
Collapse
|
252
|
Ablikim M, Achasov MN, Alberto D, Ambrose DJ, An FF, An Q, An ZH, Bai JZ, Baldini Ferroli RBF, Ban Y, Becker J, Berger N, Bertani MB, Bian JM, Boger E, Bondarenko O, Boyko I, Briere RA, Bytev V, Cai X, Calcaterra AC, Cao GF, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen Y, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denysenko I, Destefanis M, Ding Ding WL, Ding Y, Dong LY, Dong MY, Du SX, Fang J, Fang SS, Feng CQ, Fu CD, Fu JL, Gao Y, Geng C, Goetzen K, Gong WX, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo YP, Han YL, Hao XQ, Harris FA, He KL, He M, He ZY, Heng YK, Hou ZL, Hu HM, Hu JF, Hu T, Huang B, Huang GM, Huang JS, Huang XT, Huang YP, Hussain T, Ji CS, Ji Q, Ji XB, Ji XL, Jia LK, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kalantar-Nayestanaki N, Kavatsyuk M, Kuehn W, Lai W, Lange JS, Leung JKC, Li CH, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li K, Li L, Li NB, Li QJ, Li SL, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Liu BJ, Liu CL, Liu CX, Liu CY, Liu FH, Liu F, Liu F, Liu H, Liu HB, Liu HH, Liu HM, Liu HW, Liu JP, Liu K, Liu K, Liu KY, Liu Q, Liu SB, Liu X, Liu XH, Liu YB, Liu Y, Liu ZA, Liu Z, Liu Z, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Ma CL, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XY, Maggiora M, Malik QA, Mao H, Mao YJ, Mao ZP, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Muchnoi NY, Nefedov Y, Nikolaev IB, Ning Z, Olsen SL, Ouyang Q, Pacetti SP, Park JW, Pelizaeus M, Peters K, Ping JL, Ping RG, Poling R, Pun CSJ, Qi M, Qian S, Qiao CF, Qin XS, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schulze J, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun XD, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Thorndike EH, Tian HL, Toth D, Varner GS, Wang B, Wang BQ, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang Q, Wang QJ, Wang SG, Wang XF, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wen QG, Wen SP, Wiedner U, Wu LH, Wu N, Wu W, Wu Z, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu GM, Xu H, Xu QJ, Xu XP, Xu Y, Xu ZR, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang T, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yu BX, Yu CX, Yu SP, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo AZ, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang J, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang SH, Zhang TR, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang YS, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao J, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zheng ZP, Zhong B, Zhong J, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu XW, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH, Zuo JX. Spin-parity analysis of pp¯ mass threshold structure in J/ψ and ψ(3686) radiative decays. PHYSICAL REVIEW LETTERS 2012; 108:112003. [PMID: 22540467 DOI: 10.1103/physrevlett.108.112003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2011] [Indexed: 05/31/2023]
Abstract
A partial wave analysis of the pp¯ mass-threshold enhancement in the reaction J/ψ→γpp¯ is used to determine its J(PC) quantum numbers to be 0(-+), its peak mass to be below threshold at M=1832(-5)(+19)(stat)(-17)(+18)(syst)±19(model) MeV/c(2), and its total width to be Γ<76 MeV/c(2) at the 90% C.L. The product of branching ratios is measured to be BR[J/ψ→γX(pp¯)]BR[X(pp¯)→pp¯]=[9.0(-1.1)(+0.4)(stat)(-5.0)(+1.5)(syst)±2.3(model)]×10(-5). A similar analysis performed on ψ(3686)→γpp¯ decays shows, for the first time, the presence of a corresponding enhancement with a production rate relative to that for J/ψ decays of R=[5.08(-0.45)(+0.71)(stat)(-3.58)(+0.67)(syst)±0.12(model)]%.
Collapse
|
253
|
Zheng B, Zhou R, Gong Y, Yang X, Shan Q. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines. Int J Lab Hematol 2011; 34:237-47. [PMID: 22145750 DOI: 10.1111/j.1751-553x.2011.01384.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
INTRODUCTION To study the effect of bortezomib alone or in combination with daunorubicin (DNR) on an mdr1 single-factor drug-resistant leukemia cell line K562/MDR1, a multifactor-resistant cell line K562/A02, a drug-sensitive cell line K562, and primary cells from acute myeloid leukemia patients. METHODS The cell lines were exposed to bortezomib, DNR, and bortezomib plus DNR, and cell proliferation, cell cycle, apoptosis rate, and expression of MDR1/BCL2 were analyzed. RESULTS Bortezomib potently inhibited growth and increased the apoptosis rate in the cell lines. In K562/MDR1 and K562/A02, the calcium channel blocker verapamil reduced the 50% inhibitory concentration and apoptosis rate of DNR, a P-gp protein substrate, but not of bortezomib. Bortezomib plus DNR had synergistic effect on antiproliferation (synergistic ratio > 1). Apoptosis was substantially more increased by the combination of two drugs than by bortezomib alone. Bortezomib arrested the cell cycles of three cell lines at the G2/M stage, decreased BCL2 mRNA expression, but did not affect MDR1 mRNA levels. The antiproliferative role of bortezomib was also confirmed in primary leukemia cells. CONCLUSION Bortezomib is a promising potential therapy for acute leukemia, especially mdr1 drug-resistant leukemia.
Collapse
|
254
|
Ablikim M, Achasov MN, Alberto D, An Q, An ZH, Bai JZ, Baldini R, Ban Y, Becker J, Berger N, Bertani M, Bian JM, Bondarenko O, Boyko I, Briere RA, Bytev V, Cai X, Calcaterra AC, Cao GF, Cao XX, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen Y, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denysenko I, Destefanis M, Ding Y, Dong LY, Dong MY, Du SX, Fan RR, Fang J, Fang SS, Feng CQ, Fu CD, Fu JL, Gao Y, Geng C, Goetzen K, Gong WX, Greco M, Grishin S, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo YP, Hao XQ, Harris FA, He KL, He M, He ZY, Heng YK, Hou ZL, Hu HM, Hu JF, Hu T, Huang B, Huang GM, Huang JS, Huang XT, Huang YP, Hussain T, Ji CS, Ji Q, Ji XB, Ji XL, Jia LK, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kalantar-Nayestanaki N, Kavatsyuk M, Komamiya S, Kuehn W, Lange JS, Leung JKC, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li K, Li L, Li NB, Li QJ, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao XT, Liu BJ, Liu BJ, Liu CL, Liu CX, Liu CY, Liu FH, Liu F, Liu F, Liu GC, Liu H, Liu HB, Liu HH, Liu HM, Liu HW, Liu JP, Liu K, Liu K, Liu KY, Liu Q, Liu SB, Liu X, Liu XH, Liu YB, Liu YW, Liu Y, Liu ZA, Liu ZQ, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Ma CL, Ma FC, Ma HL, Ma QM, Ma T, Ma X, Ma XY, Maggiora M, Malik QA, Mao H, Mao YJ, Mao ZP, Messchendorp JG, Min J, Mitchell RE, Mo XH, Muchnoi NY, Nefedov Y, Nikolaev IB, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Pelizaeus M, Peters K, Ping JL, Ping RG, Poling R, Pun CSJ, Qi M, Qian S, Qiao CF, Qin XS, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schulze J, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Sonoda S, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun XD, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tian HL, Toth D, Varner GS, Wan X, Wang BQ, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang Q, Wang SG, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wen QG, Wen SP, Wiedner U, Wu LH, Wu N, Wu W, Wu Z, Xiao ZJ, Xie YG, Xu GF, Xu GM, Xu H, Xu QJ, Xu XP, Xu Y, Xu ZR, Xu ZZ, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang M, Yang T, Yang Y, Yang YX, Ye M, Ye MH, Yu BX, Yu CX, Yu L, Yu SPY, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang J, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang SH, Zhang TR, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao J, Zhao J, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhao ZL, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zheng ZP, Zhong B, Zhong J, Zhong L, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu XW, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH, Zuo JX. ηπ+ π- resonant structure around 1.8 GeV/c(2) and η(1405) in J/ψ → ωηπ+ π-. PHYSICAL REVIEW LETTERS 2011; 107:182001. [PMID: 22107625 DOI: 10.1103/physrevlett.107.182001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/09/2011] [Indexed: 05/31/2023]
Abstract
We present results of a study of the decay J/ψ → ωηπ+ π- using a sample of (225.2 ± 2.8) × 10(6) J/ψ events collected by the BESIII detector, and report the observation of a new process J/ψ → ωX(1870) with a statistical significance of 7.2σ, in which X(1870) decays to a(0)(±)(980)π±. Fitting to ηπ+ π- mass spectrum yields a mass M = 1877.3 ± 6.3(stat)(-7.4)(+3.4)(syst) MeV/c(2), a width Γ = 57 ± 12(stat)(-4)(+19)(syst) MeV/c(2), and a product branching fraction B(J/ψ → ωX) × B(X→a(0)(±)(980)π±) × B(a(0) (±)(980) → ηπ±) = [1.50 ± 0.26(stat)(-0.36)(+0.72) (syst)] × 10(-4). Signals for J/ψ → ωf(1)(1285) and J/ψ → ω η(1405) are also clearly observed and measured.
Collapse
|
255
|
Zheng B, Di Y. Individual Target Margin for Stereotactic Body Radiation Therapy of Lung Cancer. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.1486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
256
|
Morgan⁎ M, Zheng B, van den Kant H, Hazen L, van Roest M, Folkerts G, Kraneveld A. The development of Th17 responses towards gut antigens during colitis requires both intestinal inflammation and TLR2/6 stimulation. Eur J Pharmacol 2011. [DOI: 10.1016/j.ejphar.2011.09.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
257
|
Ablikim M, Achasov MN, An L, An Q, An ZH, Bai JZ, Baldini R, Ban Y, Becker J, Berger N, Bertani M, Bian JM, Bondarenko O, Boyko I, Briere RA, Bytev V, Cai X, Cao GF, Cao XX, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen Y, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denysenko I, Destefanis M, Ding Y, Dong LY, Dong MY, Du SX, Duan MY, Fan RR, Fang J, Fang SS, Feng CQ, Fu CD, Fu JL, Gao Y, Geng C, Goetzen K, Gong WX, Greco M, Grishin S, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo YP, Hao XQ, Harris FA, He KL, He M, He ZY, Heng YK, Hou ZL, Hu HM, Hu JF, Hu T, Huang B, Huang GM, Huang JS, Huang XT, Huang YP, Hussain T, Ji CS, Ji Q, Ji XB, Ji XL, Jia LK, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kavatsyuk M, Komamiya S, Kuehn W, Lange JS, Leung JKC, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li L, Li NB, Li QJ, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Liu BJ, Liu BJ, Liu CL, Liu CX, Liu CY, Liu FH, Liu F, Liu F, Liu GC, Liu H, Liu HB, Liu HM, Liu HW, Liu JP, Liu K, Liu KY, Liu Q, Liu SB, Liu X, Liu XH, Liu YB, Liu YW, Liu Y, Liu ZA, Liu ZQ, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Ma CL, Ma FC, Ma HL, Ma QM, Ma T, Ma X, Ma XY, Maggiora M, Malik QA, Mao H, Mao YJ, Mao ZP, Messchendorp JG, Min J, Mitchell RE, Mo XH, Muchnoi NY, Nefedov Y, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Pelizaeus M, Peters K, Ping JL, Ping RG, Poling R, Pun CSJ, Qi M, Qian S, Qiao CF, Qin XS, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schulze J, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Sonoda S, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun XD, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tang XF, Tian HL, Toth D, Varner GS, Wan X, Wang BQ, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang Q, Wang SG, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wen QG, Wen SP, Wiedner U, Wu LH, Wu N, Wu W, Wu Z, Xiao ZJ, Xie YG, Xu GF, Xu GM, Xu H, Xu Y, Xu ZR, Xu ZZ, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang M, Yang T, Yang Y, Yang YX, Ye M, Ye MH, Yu BX, Yu CX, Yu L, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang J, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang SH, Zhang TR, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao J, Zhao J, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhao ZL, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zheng ZP, Zhong B, Zhong J, Zhong L, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu XW, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH, Zuo JX, Zweber P. Observation of χ(c1) decays into vector meson pairs φφ, ωω, and ωφ. PHYSICAL REVIEW LETTERS 2011; 107:092001. [PMID: 21929228 DOI: 10.1103/physrevlett.107.092001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2011] [Indexed: 05/31/2023]
Abstract
Using (106±4)×10⁻⁶ ψ(3686) events accumulated with the BESIII detector at the BEPCII e⁺e⁻ collider, we present the first measurement of decays of χ(c1) to vector meson pairs φφ, ωω, and ωφ. The branching fractions are measured to be (4.4±0.3±0.5)×10⁻⁴, (6.0±0.3±0.7)×10⁻⁴, and (2.2±0.6±0.2)×10⁻⁵, for χ(c1)→φφ, ωω, and ωφ, respectively, which indicates that the hadron helicity selection rule is significantly violated in χ(cJ) decays. In addition, the measurement of χ(cJ)→ωφ provides the first indication of the rate of doubly OZI-suppressed χ(cJ) decay. Finally, we present improved measurements for the branching fractions of χ(c0) and χ(c2) to vector meson pairs.
Collapse
|
258
|
Zheng B, Ma B, Yang K, Mi D. Meta-analysis of randomized controlled trials comparing D2 and D4 lymphadenectomy for gastric cancer. Eur Surg 2011. [DOI: 10.1007/s10353-011-0614-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
259
|
Zheng B, Uenuma M, Iwahori K, Okamoto N, Naito M, Ishikawa Y, Uraoka Y, Yamashita I. Sterically controlled docking of gold nanoparticles on ferritin surface by DNA hybridization. NANOTECHNOLOGY 2011; 22:275312. [PMID: 21613737 DOI: 10.1088/0957-4484/22/27/275312] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Novel assemblies of DNA-functionalized gold nanoparticles (DNA-GNPs) have received considerable interest due to their fascinating properties which are desired for various detection applications. In this study, we present innovative GNP assemblies which have a cage-shaped protein ferritin in the center, and discrete GNPs sterically surrounding the central ferritin. These assemblies were constructed by hybridizing DNA-GNP to chemically DNA-modified ferritin, which has a hollow cavity or an iron NP core. Subsequent gel electrophoresis purification and transmission electron microscopy observation showed that ferritin/DNA/GNP assemblies were successfully constructed and can be isolated as independent functional units, which can be used to investigate not only the interaction between the GNPs of complicated GNP clusters but also the interaction between the GNPs and the internalized NP.
Collapse
|
260
|
Huang Z, Cao J, Li T, Zheng B, Wang M, Zheng R. Efficacy and safety of ultrasound-guided local injections of etanercept into entheses of ankylosing spondylitis patients with refractory Achilles enthesitis. Clin Exp Rheumatol 2011; 29:642-649. [PMID: 21906429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2010] [Accepted: 03/08/2011] [Indexed: 05/31/2023]
Abstract
OBJECTIVES Enthesitis is one of the most common and specific manifestations of ankylosing spondylitis (AS). However, the treatment of enthesitis is still a challenge for rheumatologist so far, especially to those AS patients with serious enthesitis. This study aimed to evaluate the efficacy and safety of ultrasound (US)-guided local injection of etanercept into entheses of AS patients with refractory Achilles enthesitis. METHODS Twelve AS patients with severe unilateral refractory Achilles enthesitis were enrolled. Among them, 5 patients received US-guided local injection of etanercept and the other 7 received betamethasone. BASDAI, BASFI, VAS of the affected heel, the percentage of ASAS20 responders, CRP, ESR and any adverse events were recorded at baseline, 2, 4, 8 and 12 weeks after the treatment. US was also used to evaluate the corresponding entheses at baseline and every follow-up visit. RESULTS The BASDAI, BASFI, VAS of the affected heel, CRP, ESR, the percentage of ASAS20 responders and the regional blood flow signals detected by colour Doppler were all improved in both the etanercept group and the betamethasone group, at each follow-up visit compared to the baseline data (p<0.05). There were no significant differences in the improvements of any of the above parameters between the two groups (p>0.05). In addition, there were no adverse events from the etanercept group, except for the mild acid bilges feeling during the injection procedure, while 1 patient from the betamethasone group developed mild local atrophoderma since the week 4 follow-up visit and the atrophoderma kept stable at the 2 subsequent visits. CONCLUSIONS US-guided local injection of etanercept might be a highly effective, safe and well tolerated treatment for Achilles enthesitis in patients with AS.
Collapse
|
261
|
Liu Y, Zhang X, Liang Y, Yu H, Chen X, Zheng T, Zheng B, Wang L, Zhao L, Shi C, Zhao S. Targeting X box-binding protein-1 (XBP1) enhances sensitivity of glioma cells to oxidative stress. Neuropathol Appl Neurobiol 2011; 37:395-405. [DOI: 10.1111/j.1365-2990.2010.01155.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
262
|
Guo L, Tian J, Guo Z, Zheng B, Han S. The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoantibodies and exacerbates glomerulonephritis in murine lupus. Clin Exp Immunol 2011; 164:227-35. [PMID: 21352206 DOI: 10.1111/j.1365-2249.2011.04332.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Immunoglobulin (Ig)D is the major antigen receptor isotype co-expressed with IgM on the surface of most peripheral B cells in mice and humans. However, the biological role of IgD as B cell receptor (BCR) has remained unclear. Previous studies have indicated that IgD may play a role in B cell tolerance. To understand the role of IgD in B cell tolerance and autoimmunity, we have examined the development of autoimmune syndrome in lpr mice deficient for IgD. The present study showed that IgD deficiency did not alter lymphoproliferation and lymphocyte activation in lpr mice. The survival and proliferation of B cells were not affected by the absence of IgD, indicating that IgD BCR-mediated signals do not have an important role in negative selection of autoreactive B cell clones. Interestingly, compared to IgD-competent littermates, lpr mice with IgD deficiency had elevated autoantibody production, increased deposition of immune complex in the kidney and more severe nephritis. Accumulation of abnormal CD4(-) CD8(-) αβ(+) T cells was accelerated in IgD(-/-) lpr mice compared to lpr mice. These results suggest that IgD BCR-mediated signals may be involved in the differentiation of autoreactive B cells into plasma cells and abnormal T cell expansion.
Collapse
|
263
|
Zheng B, Sumkin JH, Zuley ML, Lederman D, Wang X, Gur D. Computer-aided detection of breast masses depicted on full-field digital mammograms: a performance assessment. Br J Radiol 2011; 85:e153-61. [PMID: 21343322 DOI: 10.1259/bjr/51461617] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVES To investigate the feasibility of converting a computer-aided detection (CAD) scheme for digitised screen-film mammograms to full-field digital mammograms (FFDMs) and assessing CAD performance on a large database. METHODS The database included 6478 FFDM images acquired on 1120 females, with 525 cancer cases and 595 negative cases. The database was divided into five case groups: (1) cancer detected during screening, (2) interval cancers, (3) "high-risk" recommended for surgical excision, (4) recalled but negative and (5) negative (not recalled). A previously developed CAD scheme for masses depicted on digitised images was converted and re-optimised for FFDM images while keeping the same image-processing structure. CAD performance was analysed on the entire database. RESULTS The case-based sensitivity was 75.6% (397/525) for the current mammograms and 40.8% (42/103) for the prior mammograms deemed negative during clinical interpretation but "visible" during retrospective review. The region-based sensitivity was 58.1% (618/1064) for the current mammograms and 28.4% (57/201) for the prior mammograms. The CAD scheme marked 55.7% (221/397) and 35.7% (15/42) of the masses on both views of the current and the prior examinations, respectively. The overall CAD-cued false-positive rate was 0.32 per image, ranging from 0.29 to 0.51 for the five case groups. CONCLUSION This study indicated that (1) digitised image-based CAD can be converted for FFDMs while performing at a comparable, or better, level; (2) CAD detects a substantial fraction of cancers depicted on prior examinations, albeit most having been marked only on one view; and (3) CAD tends to mark more false-positive results on "difficult" negative cases that are more visually difficult for radiologists to interpret.
Collapse
|
264
|
Ren FYG, Michel J, Sun-Paduano Q, Zheng B, Kitagawa H, Jacobson D, Poate J, Kimerling LC. Ic Compatible Processing of Si:Er for optoelectronics. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-301-87] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
ABSTRACTWe have fabricated the first Si:Er LED, operating at 300 K, based on an understanding of the Si-Er-O materials system. Er-doped Si (Si:Er) provides an exciting opportunity for the monolithic integration of Si based opto-electronics. In this paper, Er-Si reactivity, and Er diffusivity and solubility have been studied to establish Si:Er process compatibility with a silicon IC fabline. Er3 Si5 is the most stable silicid formed; and it can be oxidized into Er2O3 at high temperature under any oxidizing conditions. Among Er compounds, Er2O3 luminesces and Er3Si5 and ErN do not. The diffusivity of Er in Si is low and SIMS analysis yields a diffusivity D(Er) ∼ 10−12cm2/s at 1300 C and ∼ 10−15cm2/s at 900 C, and a migration enthalpy of δHm(Er) ∼ 4.6 eV. The equilibrium solubility of Er in Si is in the range of 1016 cm−3 at 1300 C. The Si:Er LED performance is compared with GaAs LEDs to demonstrate its feasibility.
Collapse
|
265
|
Ding PJ, Zheng B, Eisenbraun ET, Lanford WA, Kaloyeros AE, Hymes S, Murarka SP. Observation of Reduced Oxidation Rates for Plasmaassisted CVD Copper Films. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-309-455] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
AbstractOxidation kinetics of plasma-assisted chemical vapor deposited (PA-CVD) copper films were investigated using Rutherford backscattering spectrometry (RBS). The PA-CVD copper films were deposited using hydrogen plasma reduction of bis(hexafluoroacetylacetonato) copper(II), Cu(hfa)2, precursor. Under identical experimental conditions, PA-CVD copper films oxidize more slowly than sputtered copper films. This decrease in oxidationis manifested both as a time delay at the beginning of the oxidation of the PA-CVD copper films and as a decrease in the rate of oxide growth at oxidation temperatures of 200ºC and below. The possivation appears to be caused by the hydrogen plasma present during depostion.
Collapse
|
266
|
Ablikim M, Achasov MN, An L, An Q, An ZH, Bai JZ, Baldini R, Ban Y, Becker J, Berger N, Bertani M, Bian JM, Boyko I, Briere RA, Bytev V, Cai X, Cao GF, Cao XX, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen Y, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denysenko I, Destefanis M, Ding Y, Dong LY, Dong MY, Du SX, Duan MY, Fan RR, Fang J, Fang SS, Feldbauer F, Feng CQ, Fu CD, Fu JL, Gao Y, Geng C, Goetzen K, Gong WX, Greco M, Grishin S, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo YP, Hao XQ, Harris FA, He KL, He M, He ZY, Heng YK, Hou ZL, Hu HM, Hu JF, Hu T, Huang B, Huang GM, Huang JS, Huang XT, Huang YP, Hussain T, Ji CS, Ji Q, Ji XB, Ji XL, Jia LK, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kavatsyuk M, Komamiya S, Kuehn W, Lange JS, Leung JKC, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li L, Li NB, Li QJ, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Liu BJ, Liu BJ, Liu CL, Liu CX, Liu CY, Liu FH, Liu F, Liu F, Liu GC, Liu H, Liu HB, Liu HM, Liu HW, Liu JP, Liu K, Liu KY, Liu Q, Liu SB, Liu X, Liu XH, Liu YB, Liu YW, Liu Y, Liu ZA, Liu ZQ, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Ma CL, Ma FC, Ma HL, Ma QM, Ma T, Ma X, Ma XY, Maggiora M, Malik QA, Mao H, Mao YJ, Mao ZP, Messchendorp JG, Min J, Mitchell RE, Mo XH, Motzko C, Muchnoi NY, Nefedov Y, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Pelizaeus M, Peters K, Ping JL, Ping RG, Poling R, Pun CSJ, Qi M, Qian S, Qiao CF, Qin XS, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schulze J, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Sonoda S, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun XD, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tang XF, Tian HL, Toth D, Varner GS, Wan X, Wang BQ, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang Q, Wang SG, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wen SP, Wiedner U, Wu LH, Wu N, Wu W, Wu Z, Xiao ZJ, Xie YG, Xu GF, Xu GM, Xu H, Xu Y, Xu ZR, Xu ZZ, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang M, Yang T, Yang Y, Yang YX, Ye M, Ye MH, Yu BX, Yu CX, Yu L, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang J, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang SH, Zhang TR, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao J, Zhao J, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhao ZL, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zheng ZP, Zhong B, Zhong J, Zhong L, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu XW, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH, Zuo JX, Zweber P. Confirmation of the X(1835) and observation of the resonances X(2120) and X(2370) in J/ψ→γπ+π-η'. PHYSICAL REVIEW LETTERS 2011; 106:072002. [PMID: 21405509 DOI: 10.1103/physrevlett.106.072002] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2010] [Indexed: 05/30/2023]
Abstract
With a sample of (225.2±2.8)×10(6) J/ψ events registered in the BESIII detector, J/ψ→γπ(+)π(-)η(') is studied using two η(') decay modes: η(')→π(+)π(-)η and η(')→γρ(0). The X(1835), which was previously observed by BESII, is confirmed with a statistical significance that is larger than 20σ. In addition, in the π(+)π(-)η(') invariant-mass spectrum, the X(2120) and the X(2370), are observed with statistical significances larger than 7.2σ and 6.4σ, respectively. For the X(1835), the angular distribution of the radiative photon is consistent with expectations for a pseudoscalar.
Collapse
|
267
|
Michel J, Zheng B, Palm J, Ouellette E, Gan F, Kimerling LC. Erbium Doped Silicon for Light Emitting Devices. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-422-317] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
AbstractWe report on the excitation and de-excitation processes of erbium implanted in silicon and the integration of Si:Er light emitting devices (LED) with standard CMOS technology. We find two deexcitation processes, an Auger process below 100 K and a phonon mediated energy backtransfer above 100 K. We present the first optical voice link with a silicon LED as the emitter. Optical transmission system performance with our LED is possible below 200 K.
Collapse
|
268
|
Zheng B, Qiu Y, Jin H, Wang L, Chen X, Shi C, Zhao S. A predictive value of hyponatremia for poor outcome and cerebral infarction in high-grade aneurysmal subarachnoid haemorrhage patients. J Neurol Neurosurg Psychiatry 2011; 82:213-7. [PMID: 20667862 DOI: 10.1136/jnnp.2009.180349] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND The clinical significance of hyponatremia has not been investigated in high-grade aneurysmal subarachnoid haemorrhage (aSAH) patients. Thus, we assessed the predictive value of hyponatremia for poor outcome or cerebral infarction in high grade patients (the World Federation of Neurological Surgeons Scale (WFNS) grade 4 or 5) after aSAH. METHODS Patients with WFNS grade 4 or 5 after aSAH were selected into this study between January 2005 and January 2008. In the same period, patients with WFNS grade 1, 2 or 3 after aSAH (low grade) were also chosen into this study. Hyponatremia was determined with serum sodium measurements obtained within 9 days after aSAH. Prognosis of patients was estimated with Glasgow Outcome Scale at 3 months. The relationship between hyponatremia and poor outcome and association of hyponatremia and cerebral infarction were analysed, respectively. RESULTS A total of 124 high-grade patients were included in this study. Of those, 78 patients developed hyponatremia. Hyponatremia developed in 32.3% of cases between days 1 and 3 after aSAH, and 30.6% developed hyponatremia after 3 days post-aSAH. Multivariable analysis revealed that hyponatremia was not correlated with poor outcome in high-grade aSAH patients. Furthermore, only late-onset hyponatremia was correlated with cerebral infarction in these patients. Meanwhile, there was no significant correlation between hyponatremia and poor outcome or cerebral infarction in 259 low-grade aSAH patients. CONCLUSIONS Hyponatremia does not predict poor outcome in all-grade aSAH patients. However, late-onset hyponatremia in high-grade aSAH patients is associated with cerebral infarction. Therefore, the appropriate management of hyponatremia could be beneficial in those patients.
Collapse
|
269
|
Ablikim M, Achasov MN, An L, An Q, An ZH, Bai JZ, Baldini R, Ban Y, Becker J, Berger N, Bertani M, Bian JM, Boyko I, Briere RA, Bytev V, Cai X, Cao GF, Cao XX, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen Y, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denysenko I, Destefanis M, Ding Y, Dong LY, Dong MY, Du SX, Duan MY, Fan RR, Fang J, Fang SS, Feldbauer F, Feng CQ, Fu CD, Fu JL, Gao Y, Geng C, Goetzen K, Gong WX, Greco M, Grishin S, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo YP, Hao XQ, Harris FA, He KL, He M, He ZY, Heng YK, Hou ZL, Hu HM, Hu JF, Hu T, Huang B, Huang GM, Huang JS, Huang XT, Huang YP, Hussain T, Ji CS, Ji Q, Ji XB, Ji XL, Jia LK, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kavatsyuk M, Komamiya S, Kuehn W, Lange JS, Leung JKC, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li L, Li NB, Li QJ, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Liu BJ, Liu BJ, Liu CL, Liu CX, Liu CY, Liu FH, Liu F, Liu F, Liu GC, Liu H, Liu HB, Liu HM, Liu HW, Liu JP, Liu K, Liu KY, Liu Q, Liu SB, Liu XH, Liu YB, Liu YW, Liu Y, Liu ZA, Liu ZQ, Loehner H, Lu GR, Lu HJ, Lu JG, Lu QW, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Ma CL, Ma FC, Ma HL, Ma QM, Ma T, Ma X, Ma XY, Maggiora M, Malik QA, Mao H, Mao YJ, Mao ZP, Messchendorp JG, Min J, Mitchell RE, Mo XH, Motzko C, Muchnoi NY, Nefedov Y, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Pelizaeus M, Peters K, Ping JL, Ping RG, Poling R, Pun CSJ, Qi M, Qian S, Qiao CF, Qin XS, Qiu JF, Rashid KH, Rong G, Ruan XD, Sarantsev A, Schulze J, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song XY, Sonoda S, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun XD, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tang XF, Tian HL, Toth D, Varner GS, Wan X, Wang BQ, Wang K, Wang LL, Wang LS, Wang P, Wang PL, Wang Q, Wang SG, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wen SP, Wiedner U, Wu LH, Wu N, Wu W, Wu Z, Xiao ZJ, Xie YG, Xu GF, Xu GM, Xu H, Xu Y, Xu ZR, Xu ZZ, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang M, Yang T, Yang Y, Yang YX, Ye M, Ye MH, Yu BX, Yu CX, Yu L, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang J, Zhang JW, Zhang JY, Zhang JZ, Zhang L, Zhang SH, Zhang TR, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao J, Zhao J, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhao ZL, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zheng ZP, Zhong B, Zhong J, Zhong L, Zhou L, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu XW, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH, Zuo JX, Zweber P. Evidence for ψ' decays into γπ0 and γη. PHYSICAL REVIEW LETTERS 2010; 105:261801. [PMID: 21231643 DOI: 10.1103/physrevlett.105.261801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2010] [Indexed: 05/30/2023]
Abstract
The decays ψ'→γπ(0), γη and γη' are studied using data collected with the BESIII detector at the BEPCII e(+)e(-) collider. The processes ψ'→γπ(0) and ψ'→γη are observed for the first time with signal significances of 4.6σ and 4.3σ, respectively. The branching fractions are determined to be B(ψ'→γπ(0))=(1.58±0.40±0.13)×10(-6), B(ψ'→γη)=(1.38±0.48±0.09)×10(-6), and B(ψ'→γη')=(126±3±8)×10(-6), where the first errors are statistical and the second ones systematic.
Collapse
|
270
|
Zheng B, Uenuma M, Uraoka Y, Yamashita I. Construction of a ferritin dimer by breaking its symmetry. NANOTECHNOLOGY 2010; 21:445602. [PMID: 20935356 DOI: 10.1088/0957-4484/21/44/445602] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Ferritin has a mono-dispersed structure and biomineralization properties that allow it to form various kinds of nanoparticles and play an important role in modern nanotechnology. Independent nanoparticles synthesized in ferritin are valuable, but moreover a pair of nanoparticles can bring new properties different from those of the independent nanoparticles. In this study, by breaking ferritin's symmetry, we successfully produced ferritin dimers which provide real protein frameworks for nanoparticle dimer formation. Identical nickel hydro-oxide nanoparticle dimers were produced by simply biomineralizing ferritin dimers. The method presented here can produce multi-functional ferritin dimers with different kinds of nanoparticles.
Collapse
|
271
|
Li T, Zheng B, Huang Z, Lu H, Lin Q, Liao Z, Lin Z, Zhao L, Wang X, Gu J. Over-expression of talin 1 and integrin-linked kinase in PBMCs of patients with ankylosing spondylitis: a proteomic study. Clin Exp Rheumatol 2010; 28:828-835. [PMID: 21122263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2010] [Accepted: 05/18/2010] [Indexed: 05/30/2023]
Abstract
OBJECTIVES Ankylosing spondylitis (AS) is difficult to diagnose in its early stage due to the lack of simple and specific diagnostic indicators. This study was performed to screen candidate AS-associated proteins from peripheral blood mononuclear cells (PBMCs) of AS patients by combining a two-dimensional electrophoresis (2-DE) technique with mass spectrometry (MS) analysis. METHODS Twelve subjects consisting of 6 AS patients and 6 healthy volunteers (HVs) were enrolled in the 2-DE experiments. The protein expression patterns of PBMCs from different groups were analysed by PDQuest software, and the protein spots over/under-expressed by more than 2-fold between the two groups were identified by MS analysis. Western blot analyses were used to verify the differentially expressed proteins in 32 AS patients and 32 HVs. RESULTS Six proteins including pyruvate kinase (PK), profilin 1 (PFN1), talin 1 (TLN1), Chain A of cyclophilin A (CyPA), unknown protein (gi|16306948) and integrin-linked kinase (ILK) were identified from 10 over-expressed protein spots found by 2-DE in the AS group. Western blot experiments confirmed a higher expression of both TLN1 and ILK in AS group compared to the HV group (p<0.05). CONCLUSIONS TLN1 and ILK expressed higher in PBMCs of AS patients compared to healthy controls, which were involved in the integrin signalling pathway. The two proteins are likely novel disease-associated proteins and potential disease markers of AS.
Collapse
|
272
|
Li Y, Tomita H, Lv Y, Liu J, Xue F, Zheng B, Ike Y. Molecular characterization of erm(B)- and mef(E)-mediated erythromycin-resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010. J Appl Microbiol 2010; 110:254-65. [PMID: 20961364 DOI: 10.1111/j.1365-2672.2010.04875.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
AIMS To characterize the erm(B)- and mef(E)-mediated erythromycin-resistant Streptococcus pneumoniae clinical isolates obtained from ten hospitals located different cities in China. METHODS AND RESULTS Totally 83 S. pneumoniae were collected, and eighteen representative strains of 66 strains that exhibited erythromycin resistance were used for further characterization by antibiograms, serotyping, PFGE, MLST, DNA sequencing of the macrolide-resistance elements and mapping of the elements on the chromosome. Twelve isolates showed a high-level resistance to erythromycin, and six other isolates showed a low-level resistance to erythromycin. Thirteen isolates harboured a Tn2010 transposon (26·4 kbp) encoding the erm(B), tet(M) and mef(E) genes and were classified into three types by Tn2010 structures. The remaining five isolates harboured a Tn6002 transposon (20·9 kbp) encoding the erm(B) and tet(M) genes and were classified into three types by Tn6002 locations on the chromosome. Three of the Tn6002 elements were located within the Tn5252-like element, implying that these composed a large mobile element. The MLST analyses showed that several clones had been disseminated and that the CC271 strains carrying the Tn2010 element expressing the high-level resistance to erythromycin were predominant in China. Four new MLST strains, which were designated as ST3262, ST3263, ST3397 and ST3398 were also identified. CONCLUSIONS The erythromycin resistance determinant of S.pneumoniae that had been isolated in China was located in Tn2010 or the Tn6002 element and several clones had been disseminated, and the CC271 strains carrying the Tn2010 element expressing the high-level resistance to erythromycin were predominant in China. SIGNIFICANCE AND IMPACT OF THE STUDY This is the first molecular analysis of erythromycin-resistant Streptococcus pneumoniae clinical isolates in China, and the first report of the complete nucleotide sequence of Tn2010 (26,390 bp).
Collapse
|
273
|
Zhou NJ, Zheng B. Dynamic effect of overhangs and islands at the depinning transition in two-dimensional magnets. PHYSICAL REVIEW. E, STATISTICAL, NONLINEAR, AND SOFT MATTER PHYSICS 2010; 82:031139. [PMID: 21230057 DOI: 10.1103/physreve.82.031139] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/05/2010] [Revised: 09/05/2010] [Indexed: 05/30/2023]
Abstract
With the Monte Carlo methods, we systematically investigate the short-time dynamics of domain-wall motion in the two-dimensional random-field Ising model with a driving field (DRFIM). We accurately determine the depinning transition field and critical exponents. Through two different definitions of the domain interface, we examine the dynamics of overhangs and islands. At the depinning transition, the dynamic effect of overhangs and islands reaches maximum. We argue that this should be an important mechanism leading the DRFIM model to a different universality class from the Edwards-Wilkinson equation with quenched disorder.
Collapse
|
274
|
Atlas H, Safa N, Denis R, Garneau P, Moustarah F, Marceau S, Lebel S, Biertho L, Hould F, Marceau P, Biron S, Anvari M, Sharma A, Goldsmith CH, Lacobellis G, Cadeddu M, Misra M, Taylor V, Tarride J, Hubert E, Tiboni M, Hong D, Wiebe S, Klassen D, Bonjer J, Lawlor D, Plowman J, Ransom T, Vallis M, Ellsmere J, Graham PJ, Kaban GK, Vizhul A, Birch DW, Menezes AC, Shi X, Karmali S, Seth R, MacKenzie L, Kus A, Bell J, Carrier M, Atkins H, Boushey R, Auer R, Croome KP, Yamashita M, Aarts MA, Okrainec A, Glicksman A, Pearsall E, Pitzul K, Huang H, McLeod RS, Sarkhosh K, Robertson M, Boctor D, Lam V, Sigalet D, Johner A, Faulds J, Wiseman SM, Pemberton J, Gordon ML, Prashad C, Rambaran M, Cameron B, Neville A, Sarosi GA, Wei Y, Gibbs JO, Reda DJ, McCarthy M, Fitzgibbons RJ, Barkun JST, Fenech DS, Forbes S, Pearsall E, Chung J, Glickman A, Victor JC, Nathens A, McLeod RS, Fitzmaurice GJ, Mone F, Brown R, Cranley B, Conlon EF, Todd RAJ, O'Donnell ME, Tran TT, Kaneva PA, Finch LE, Fried GM, Mayo NE, Feldman LS, VanHouwellingen L, Vogt KN, Stewart TC, Williamson J, Parry N, DeRose G, Gray D, Harriman S, Rodych N, Hayes P, Moser M, Jamal MH, Doi S, Rousseau M, Snell L, Meterissian S, Zolfaghari S, Friedlich MS, Kurashima Y, Al-Sabah S, Kaneva PA, Feldman LS, Fried GM, Vassiliou MC, Tran TT, Kaneva PA, Mayo NE, Fried GM, Feldman LS, Pearsall E, Sheth U, Fenech D, McKenzie M, Victor JC, McLeod RS, Ghaderi I, Vaillancourt M, Sroka G, Kaneva PA, Vassiliou MC, Seagull FJ, Sutton E, Godinez C, George I, Park A, Choy I, Okrainec A, Brintzenhoff R, Prabhu A, Heniford BT, Stefanidis D, Fried GM, Feldman LS, Igric A, Vogt KN, Girotti M, Parry NG, Vinden C, Kim SHH, Zhang NN, Russo JJ, El-Salfiti IK, Kowalczuk M, Rajaee AN, Bal M, Gill MS, Lysecki PJ, Hoogenes J, Dath D, Nassar AK, Reid S, Mohaisen KN, Winch J, Omar D, Hanna WC, Mulder DS, El-Hilali MM, Khwaja KA, Jamal MH, Rayment J, Doi SA, Megueditchian A, Meterissian S, Tso D, Langer M, Blair G, Butterworth S, Vaillancourt M, Vassiliou MC, Bergman S, Fried GM, Kaneva PA, Feldman LS, Davenport E, Haggar F, Trottier D, Huynh H, Soto C, Shamji FM, Seely A, Sundaresan S, Pagliarello G, Tadros S, Yelle JD, Maziak D, Moloo H, Poulin EC, Mamazza J, Knowlton LM, Chackungal S, MacQueen KA, Anvari M, Allen C, Goldsmith C, Ghaderi I, Madani A, de Gara C, Schlachta CM, Zakrison TL, Tee MC, Chan S, Nguyen V, Yang J, Holmes D, Levine D, Bugis S, Wiseman SM, Sandhu L, Zhai J, Kennedy ED, Baxter NN, Gagliardi AR, Urbach DR, Wei AC, Sabalbal M, McAlister VC, Balayla J, Bergman S, Feldman LS, Ghitulescu G, Fraser SA, Daigle R, Urquart R, Cox M, Grunfeld E, Porter G, Hallet J, Labidi S, Clairoux A, Gagné JP, Gill RS, Manouchehri N, Liu JQ, Lee TF, Bigam DL, Cheung PY, Van Koughnett JA, Colquhoun PH, Gordon ML, Cornacchi S, Farrokhyar F, Hodgson N, Porter G, Quan ML, Wright F, Lovrics P, Datta I, Brar SS, Ball CG, Heine JA, Rothwell B, Crozier M, Ting H, Boone D, O'Regan N, Brown C, Bandrauk N, Hapgood J, Hogan M, McDonald LA, Da'as S, Sorensen PHB, Berman JN, Ameer A, Jamal M, Aljiffry M, Doi S, Hasanain M, Chaudhury P, Metrakos P, Tchervenkov J, Lapierre S, Mohammad W, Balaa N, Akil M, Mimeault R, Fairfull-Smith R, Teague BD, Butler MS, Garneau PY, Sample CB, Kapoor A, Cadeddu MO, Anvari M, Hanna WC, Jamal MH, Nguyen L, Fraser SA, Kwan K, Wallis CJD, Jones S, Fraser T, Masterso J, Blair G, Duffy D, Roberts DJ, Kirkpatrick AW, Datta I, Feliciano DV, Kortbeek JB, Laupland KB, Ball CG, Haggar F, Davenport E, Moloo H, Mamazza J, Manouchehri N, Bigam D, Churchill T, Joynt C, Cheung PY, Al-Sairafi R, Sample CB, Paquette F, Fraser SA, Feldman LS, Fried GM, Weissglas I, Ghitulescu G, Meterissian S, Bergman S, Al-Dohayan A, Al-Naami M, Bamehriz F, Madkhali A, Hallet J, LeBlanc M, Gilbert A, Daigle C, Tien G, Atkins MS, Zheng B, Tanin H, Swindells C, Meneghetti A, Panton ONM, Qayumi AK, Chhiv M, Drolet S, Sirois-Giguère É, Gilbert A, Doyle JD, Sheth U, Huang H, Pearsall E, McLeod RS, Nathens AB, Suri RR, Vora P, Kirby JM, Chan K, Smith S, Ruo L, Faryniuk A, Hochman D, Ball CG, Kirkpatrick AW, Broderick TJ, Williams DR, Kholdebarin R, Helewa R, Bracken J, Zabolotny B, Hochman D, Merchant S, Hameed M, Melck A, McGuire AL, Wilson C, Mercer D, Sharma B, Orzech N, Grantcharov T, Johner A, Taylor DC, Buczkowski AK, Chung SW, Lumb KJ, Trejos AL, Ward CDW, Naish MD, Patel RV, Schlachta CM, Davenport E, Haggar F, Moloo H, Boushey RP, Poulin EC, Mamazza J, Graybiel KM, Fernandes VT, Hoogenes J, Dath D, Mohammad W, Trottier D, Nadolny K, Poulin EC, Mamazza J, Balaa F, Diederichs B, Turner S, de Gara C, Ghitulescu GA, Filip I, Bergman S, Fraser S, Finley RJ, Mayo J, Clifton J, Yee J, Evans K, MacWilliams A, Lam S, English J, Finley C, Jacks L, Darling G, Hanna WC, Sudarshan M, Roberge D, David M, Waschke KA, Mayrand S, Ferri LE, Coughlin S, Emmerton-Coughlin H, Malthaner R, Grover HS, Basi S, Chiasson P, Basi S, Irshad K, Emmerton-Coughlin HMA, Vogt KN, Malthaner RA, Spicer JD, McDonald B, Perera R, Rousseau MC, Chan CHF, Hsu RYC, Giannias B, Ferri LE, Ahmed S, Birnbaum AE, Berz D, Fontaine JP, Dipetrillo TA, Ready NE, Ng T, Alhussaini A, Oberoi M, Threader J, Villeneuve J, Gilbert S, Shamji FM, Sundaresan S, Maziak D, Seely A, Rammohan KS, Hunt I, Chuck A, Gazala S, Valji A, Stewart K, Bedard ELR, Plourde M, Fortin D, Arab A, Inculet RI, Malthaner RA, Bharadwaj SC, Hamin T, Tan LA, Unruh HW, Srinathan SK, McGuire AL, Petsikas D, Reid K, Hopman W, Levine P, Rousseau M, Spicer J, Ferri LE, Ashrafi AS, Bond RJ, Ong SR, Ahmadi SY, Partington SL, Graham AJ, Owen S, Kelly EJ, Gelfand G, Grondin SC, McFadden SD, Paolucci EO, Weeks SG, Davis PJ, Molinari M, Topp T, Walsh MJ, Simoneau E, Hassanain M, Cabrera T, Chaudhury P, Dumitra S, Aljiffry M, Feteih I, Leduc S, Rivera J, Jamal M, Valenti D, Metrakos P, Elgadi K, Cherniak W, Chan D, Wei AC, Gallinger S, Mohammad W, Mimeault R, Fairfull-Smith R, Auer R, Balaa F, Kwan J, Hassanain M, Chaudhury P, Dey C, Gadahadh R, Salman A, Simoneau E, Meti N, Aljiffry M, Jamal M, Cabrera T, Bouganim N, Kavan P, Alcindor T, Valenti D, Metrakos P, Brar B, Sutherland F, Bégin A, Bourdonnais D, Lapointe R, Plasse M, Létourneau R, Roy A, Dagenais M, Vandenbroucke-Menu F, Bégin A, Bourdonnais D, Lapointe R, Plasse M, Létourneau R, Dagenais M, Roy A, Vandenbroucke-Menu F, Bégin A, Ismail S, Vandenbroucke-Menu F, Létourneau R, Plasse M, Roy A, Dagenais M, Lapointe R, Greco EF, Nanji S, Shah SA, Wei AC, Greig PD, Gallinger S, Cleary SP, Al-Adra DP, Anderson C, Nanji S, Ryan P, Guindi M, Selvarajah S, Greig P, McGilvray I, Taylor B, Wei A, Moulton C, Cleary SP, Gallinger S, Sandroussi C, Brace C, Kennedy E, Baxter N, Gallinger S, Wei AC, Yamashita T, Leslie K, McLean SR, Karsanji D, Dixon E, Sutherland FR, Bathe OF, Suri RR, Marcaccio MJ, Ruo L, Jamal MH, Simoneau E, Khalil JA, Hassanain M, Chaudhury P, Tchervenkov J, Metrakos P, Doi SA, Barkun JS, Barnett C, Marcaccio MJ, Hankinson JJ, Ruo L, Alawashez A, Ellsmere J, Neville A, Boutros M, Barkun J, Wiebe ME, Sandhu L, Takata JL, Kennedy ED, Baxter NN, Gagliardi AR, Urbach DR, Wei AC, Chan G, Kocha W, Reid R, Wall W, Quan D, Lovrics P, Hodgson N, Ghola G, Franic S, Goldsmith C, McCready D, Cornacchi S, Garnett A, Reedijk M, Scheer AS, McSparron JI, Schulman AR, Tuorto S, Gonen M, Gonsalves J, Fong Y, Auer RAC, Francescutti V, Coates A, Thabane L, Goldsmith CH, Levine M, Simunovic M, Richardson DP, Porter G, Johnson PM, Leon-Carlyle M, Schmocker S, O'Connor BI, Victor JC, Baxter NN, Smith AJ, McLeod RS, Kennedy ED, Chan CHF, Arabzadeh A, DeMarte L, Spicer JD, Turbide C, Brodt P, Beauchemin N, Ferri LE, Zih F, Panzarella T, Hummel C, Petronis J, McCart A, Swallow C, Mathieson A, Ridgway PF, Ko YJ, Smith AJ, Gieni M, Dickson L, Sne N, Avram R, Farrokhyar F, Smith M, Giacomantonio C, Hoskin D, Doyon C, Martin G, Patocskai E, Brar SS, Wright F, Okrainec A, Smith AJ, Bischof DA, Maier B, Fitch M, Wright FC, Baliski CR, Kluftinger A, MacLeod M, Kwong S, Racz JM, Fortin A, Latosinsky S, Messenger DE, Kirsch R, McLeod RS, Aslani N, Heidary B, Prabhu KL, Raval M, Phang PT, Brow C, Richardson DP, Porter G, Johnson PM, Moloo H, Haggar F, Duhaime S, Hutton B, Grimshaw J, Coyle D, Poulin EC, Mamazza J, Boushey RP, Paun BC, Shaheen AAM, Dixon E, Maclean AR, Buie WD, Moustarah F, Talarico J, Zink J, Gatmaitan P, Schauer P, Chand B, Brethauer S, Martel G, Duhaime S, Ramsay CR, Barkun JS, Ferguson DA, Boushey RP, Palter VN, MacRae HM, Grantcharov TP, Messenger DE, Victor JC, O'Connor BI, MacRae HM, McLeod RS, Al-Sabah S, Feldman LS, Charlebois P, Stein B, Kaneva PA, Fried GM, Liberman AS, Borowiec AM, Karmal S, Apriasz I, Mysliwiec B, Hussain N, Ott M, Reynolds R, Lum A, Williams LJ, Morash R, Shin S, Smylie J, Moloo H, Auer R, Poulin EC, Mamazza J, Watters J, Fung-Kee-Fung M, Boushey RP, Pelletier JS, de Gara CJ, White J, Ghosh S, Schiller D, Drolet S, Paolucci EO, Heine J, Buie WD, Maclean AR, Barnes A, Liang S, Auer R, Moloo H, Mamazza J, Poulin EC, Boushey RP, Klevan AE, Dalvi AA, Ramsay JA, Stephen WJ, Nhan C, Driman DK, Raby M, Smith AJ, Hunter A, Srigley J, McLeod RS, Zolfaghari S, Auer R, Moloo H, Mamazza J, Friedlich M, Poulin EC, Stern HS, Boushey RP, Scheer AS, Boushey RP, Liang S, Doucette S, O'Connor AM, Moher D. Canadian Surgery Forum. Can J Surg 2010; 53:S51-S104. [PMID: 35488396 PMCID: PMC2912011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023] Open
|
275
|
Zheng B, Liang J. WE-D-204B-06: Does the Shape and Size of Clinical Target Volume Affect the Planning Target Volume Margin? Med Phys 2010. [DOI: 10.1118/1.3469403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|